Lithium and carbamazepine therapy in a patient with manic depressive illness: Clinical effects, interactions and side effects

Research output: Contribution to journalArticlepeer-review

Abstract

This report describes a manic depressive patient who demonstrated refractoriness to pharmacotherapy, along with several side effects and drug interactions throughout the various stages of treatment with lithium, carbamazepine and a combination of these drugs. Possible mechanisms and the implications of using these drugs to treat manic depressive illness are discussed.

Original languageEnglish
Pages (from-to)295-298
Number of pages4
JournalIsrael Journal of Psychiatry and Related Sciences
Volume24
Issue number4
StatePublished - 1987
Externally publishedYes

Fingerprint

Dive into the research topics of 'Lithium and carbamazepine therapy in a patient with manic depressive illness: Clinical effects, interactions and side effects'. Together they form a unique fingerprint.

Cite this